Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024

Posted on by

STOCKHOLM, Feb. 8, 2024 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023. Fourth Quarter 2023 Total revenue increased 14 per cent, 15 per cent at constant exchange rates, (CER), to SEK 6,844 M (5,991) Haematology revenue…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.